(TAC) TransAlta - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA89346D1078
Stock: Electricity, Hydro, Wind, Solar, Gas
Total Rating 38
Risk 46
Buy Signal 0.14
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.60% |
| Yield on Cost 5y | 2.75% |
| Yield CAGR 5y | 5.31% |
| Payout Consistency | 91.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 51.5% |
| Relative Tail Risk | -13.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 6.41 |
| Character TTM | |
|---|---|
| Beta | 1.118 |
| Beta Downside | 1.358 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.26% |
| CAGR/Max DD | 0.36 |
Description: TAC TransAlta January 11, 2026
TransAlta Corp (NYSE:TAC) is a Canadian-based independent power producer that develops, generates, and markets electricity across five segments: Hydro (≈ 922 MW), Wind & Solar (≈ 2,057 MW plus battery storage), Gas (≈ 2,775 MW), Energy Transition (≈ 671 MW of coal plus the Skookumchuck hydro project and mine-reclamation activities), and Energy Marketing, which trades power, natural gas, and environmental products to a diversified customer base.
Key recent metrics show the company’s renewable portfolio expanding at roughly 10 % annual capacity growth, driven by new wind farms in the U.S. Midwest and solar projects in Ontario; FY 2023 adjusted EBITDA was about $1.2 billion, with a weighted-average generation cost advantage of ~ $20 /MWh versus the North American average. The firm’s earnings are sensitive to Canadian carbon-pricing policies (≈ $30 /tonne CO₂ in Alberta) and to U.S. natural-gas price volatility, both of which have historically contributed > 15 % of net income variance.
For a deeper, data-rich assessment of TAC’s valuation dynamics, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -141.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.21 > 1.0 |
| NWC/Revenue: -15.78% < 20% (prev -20.96%; Δ 5.18% < -1%) |
| CFO/TA 0.07 > 3% & CFO 630.0m > Net Income -141.0m |
| Net Debt (4.20b) to EBITDA (720.0m): 5.84 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (310.0m) vs 12m ago 4.73% < -2% |
| Gross Margin: 53.54% > 18% (prev 0.62%; Δ 5293 % > 0.5%) |
| Asset Turnover: 28.31% > 50% (prev 32.25%; Δ -3.94% > 0%) |
| Interest Coverage Ratio: 0.47 > 6 (EBITDA TTM 720.0m / Interest Expense TTM 283.0m) |
Altman Z'' -1.07
| A: -0.04 (Total Current Assets 1.46b - Total Current Liabilities 1.85b) / Total Assets 8.89b |
| B: -0.30 (Retained Earnings -2.63b / Total Assets 8.89b) |
| C: 0.02 (EBIT TTM 133.0m / Avg Total Assets 8.77b) |
| D: 0.07 (Book Value of Equity 540.0m / Total Liabilities 7.28b) |
| Altman-Z'' Score: -1.07 = CCC |
Beneish M -3.07
| DSRI: 0.86 (Receivables 601.0m/783.0m, Revenue 2.48b/2.79b) |
| GMI: 1.15 (GM 53.54% / 61.73%) |
| AQI: 1.17 (AQ_t 0.18 / AQ_t-1 0.15) |
| SGI: 0.89 (Revenue 2.48b / 2.79b) |
| TATA: -0.09 (NI -141.0m - CFO 630.0m) / TA 8.89b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of TAC shares?
As of February 07, 2026, the stock is trading at USD 13.24 with a total of 1,499,526 shares traded.
Over the past week, the price has changed by +3.60%, over one month by +4.09%, over three months by -11.09% and over the past year by +23.76%.
Over the past week, the price has changed by +3.60%, over one month by +4.09%, over three months by -11.09% and over the past year by +23.76%.
Is TAC a buy, sell or hold?
TransAlta has received a consensus analysts rating of 3.73.
Therefor, it is recommend to hold TAC.
- StrongBuy: 3
- Buy: 3
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the TAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.6 | 2.3% |
| Analysts Target Price | 13.6 | 2.3% |
| ValueRay Target Price | 13.5 | 1.9% |
TAC Fundamental Data Overview February 04, 2026
Market Cap CAD = 5.17b (3.79b USD * 1.3664 USD.CAD)
P/E Forward = 46.9484
P/S = 1.5241
P/B = 8.7213
P/EG = -2.34
Revenue TTM = 2.48b CAD
EBIT TTM = 133.0m CAD
EBITDA TTM = 720.0m CAD
Long Term Debt = 3.50b CAD (from longTermDebt, last quarter)
Short Term Debt = 919.0m CAD (from shortLongTermDebt, last quarter)
Debt = 4.56b CAD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.20b CAD (from netDebt column, last quarter)
Enterprise Value = 9.52b CAD (5.17b + Debt 4.56b - CCE 211.0m)
Interest Coverage Ratio = 0.47 (Ebit TTM 133.0m / Interest Expense TTM 283.0m)
EV/FCF = 27.13x (Enterprise Value 9.52b / FCF TTM 351.0m)
FCF Yield = 3.69% (FCF TTM 351.0m / Enterprise Value 9.52b)
FCF Margin = 14.13% (FCF TTM 351.0m / Revenue TTM 2.48b)
Net Margin = -5.68% (Net Income TTM -141.0m / Revenue TTM 2.48b)
Gross Margin = 53.54% ((Revenue TTM 2.48b - Cost of Revenue TTM 1.15b) / Revenue TTM)
Gross Margin QoQ = 28.29% (prev 77.14%)
Tobins Q-Ratio = 1.07 (Enterprise Value 9.52b / Total Assets 8.89b)
Interest Expense / Debt = 1.71% (Interest Expense 78.0m / Debt 4.56b)
Taxrate = 25.08% (80.0m / 319.0m)
NOPAT = 99.6m (EBIT 133.0m * (1 - 25.08%))
Current Ratio = 0.79 (Total Current Assets 1.46b / Total Current Liabilities 1.85b)
Debt / Equity = 2.97 (Debt 4.56b / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 5.84 (Net Debt 4.20b / EBITDA 720.0m)
Debt / FCF = 11.98 (Net Debt 4.20b / FCF TTM 351.0m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.61% (Net Income -141.0m / Total Assets 8.89b)
RoE = -8.56% (Net Income TTM -141.0m / Total Stockholder Equity 1.65b)
RoCE = 2.59% (EBIT 133.0m / Capital Employed (Equity 1.65b + L.T.Debt 3.50b))
RoIC = 1.92% (NOPAT 99.6m / Invested Capital 5.20b)
WACC = 5.93% (E(5.17b)/V(9.73b) * Re(10.03%) + D(4.56b)/V(9.73b) * Rd(1.71%) * (1-Tc(0.25)))
Discount Rate = 10.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.32%
[DCF Debug] Terminal Value 80.65% ; FCFF base≈389.0m ; Y1≈255.4m ; Y5≈116.5m
Fair Price DCF = N/A (negative equity: EV 3.68b - Net Debt 4.20b = -528.2m; debt exceeds intrinsic value)
EPS Correlation: -29.92 | EPS CAGR: -17.75% | SUE: -0.38 | # QB: 0
Revenue Correlation: -22.05 | Revenue CAGR: 0.22% | SUE: 2.29 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=-0.010 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.24 | Chg30d=-0.100 | Revisions Net=+0 | Growth EPS=+50.6% | Growth Revenue=-21.5%
P/E Forward = 46.9484
P/S = 1.5241
P/B = 8.7213
P/EG = -2.34
Revenue TTM = 2.48b CAD
EBIT TTM = 133.0m CAD
EBITDA TTM = 720.0m CAD
Long Term Debt = 3.50b CAD (from longTermDebt, last quarter)
Short Term Debt = 919.0m CAD (from shortLongTermDebt, last quarter)
Debt = 4.56b CAD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.20b CAD (from netDebt column, last quarter)
Enterprise Value = 9.52b CAD (5.17b + Debt 4.56b - CCE 211.0m)
Interest Coverage Ratio = 0.47 (Ebit TTM 133.0m / Interest Expense TTM 283.0m)
EV/FCF = 27.13x (Enterprise Value 9.52b / FCF TTM 351.0m)
FCF Yield = 3.69% (FCF TTM 351.0m / Enterprise Value 9.52b)
FCF Margin = 14.13% (FCF TTM 351.0m / Revenue TTM 2.48b)
Net Margin = -5.68% (Net Income TTM -141.0m / Revenue TTM 2.48b)
Gross Margin = 53.54% ((Revenue TTM 2.48b - Cost of Revenue TTM 1.15b) / Revenue TTM)
Gross Margin QoQ = 28.29% (prev 77.14%)
Tobins Q-Ratio = 1.07 (Enterprise Value 9.52b / Total Assets 8.89b)
Interest Expense / Debt = 1.71% (Interest Expense 78.0m / Debt 4.56b)
Taxrate = 25.08% (80.0m / 319.0m)
NOPAT = 99.6m (EBIT 133.0m * (1 - 25.08%))
Current Ratio = 0.79 (Total Current Assets 1.46b / Total Current Liabilities 1.85b)
Debt / Equity = 2.97 (Debt 4.56b / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 5.84 (Net Debt 4.20b / EBITDA 720.0m)
Debt / FCF = 11.98 (Net Debt 4.20b / FCF TTM 351.0m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.61% (Net Income -141.0m / Total Assets 8.89b)
RoE = -8.56% (Net Income TTM -141.0m / Total Stockholder Equity 1.65b)
RoCE = 2.59% (EBIT 133.0m / Capital Employed (Equity 1.65b + L.T.Debt 3.50b))
RoIC = 1.92% (NOPAT 99.6m / Invested Capital 5.20b)
WACC = 5.93% (E(5.17b)/V(9.73b) * Re(10.03%) + D(4.56b)/V(9.73b) * Rd(1.71%) * (1-Tc(0.25)))
Discount Rate = 10.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.32%
[DCF Debug] Terminal Value 80.65% ; FCFF base≈389.0m ; Y1≈255.4m ; Y5≈116.5m
Fair Price DCF = N/A (negative equity: EV 3.68b - Net Debt 4.20b = -528.2m; debt exceeds intrinsic value)
EPS Correlation: -29.92 | EPS CAGR: -17.75% | SUE: -0.38 | # QB: 0
Revenue Correlation: -22.05 | Revenue CAGR: 0.22% | SUE: 2.29 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=-0.010 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.24 | Chg30d=-0.100 | Revisions Net=+0 | Growth EPS=+50.6% | Growth Revenue=-21.5%